Zdrowie i gospodarka · 01/10/2018
FDA Releases Draft Guidance for Master Protocols in Oncology Drug Development
The FDA has released a draft guidance for industry outlining strategies for efficient clinical trial design to expedite the development of oncology drugs and biologics, enabling simultaneous evaluation of multiple drugs and cancer types in a single trial structure.